ORCA is making its Regional Day Pass fare permanent, a move aimed at improving affordability and accessibility for transit ...
From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 million upfront, building out another cancer-targeting approach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback